Developments in the online sale of pharmaceuticals in the EU

No SPC for nab-paclitaxel and, by the way, how will Brexit affect SPCs?
In this article, Gustaf Duhs, Partner and Head of Competition and Regulatory Law at Stevens & Bolton LLP, sets out a brief summary of the recent case before the CJEU relating to fixed pharmacy prices involving online pharmacy DocMorris and what this ruling means for the online sale of pharmaceuticals in Europe; further, Gustaf considers the latest developments in Germany and more generally in the EU following the CJEU’s decision on the matter.
Article first published in Digital Health Legal, June 2017. Download the full article here.

Contact our experts for further advice

View profile for Gustaf DuhsGustaf Duhs

Search our site